BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14691579)

  • 21. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
    Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
    Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
    N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
    Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
    N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between level of platelet inhibition after early use of abciximab and myocardial reperfusion in ST-elevation acute myocardial Infarction treated by primary percutaneous coronary intervention.
    Pérez de Prado A; Fernández-Vázquez F; Cuellas JC; Alonso-Orcajo N; Carbonell R; Pascual C; Olalla C; Diego A; de Miguel A; Calabozo RG
    Am J Cardiol; 2006 Mar; 97(6):798-803. PubMed ID: 16516579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
    Bojesen SE; Juul K; Schnohr P; Tybjaerg-Hansen A; Nordestgaard BG;
    J Am Coll Cardiol; 2003 Aug; 42(4):661-7. PubMed ID: 12932598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
    Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
    J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The a1/a2 polymorphism of the glycoprotein IIIa gene and myocardial infarction in Caucasians with type 2 diabetes.
    Nikolajević-Starčević J; Petrovič D
    Mol Biol Rep; 2013 Mar; 40(3):2077-81. PubMed ID: 23184042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke.
    Rivera-García BE; Esparza-García JC; Aceves-Chimal JL; Leaños-Miranda A; Majluf-Cruz A; Isordia-Salas I
    Mol Cell Biochem; 2013 Dec; 384(1-2):163-71. PubMed ID: 24005535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival.
    Oksala NK; Heikkinen M; Mikkelsson J; Pohjasvaara T; Kaste M; Erkinjuntti T; Karhunen PJ
    Stroke; 2007 Jan; 38(1):50-5. PubMed ID: 17138951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.
    Ridker PM; Hennekens CH; Schmitz C; Stampfer MJ; Lindpaintner K
    Lancet; 1997 Feb; 349(9049):385-8. PubMed ID: 9033464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary thrombophilia in Mexico IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Camacho-Alarcón C; Reyes-Nuñez V; Moncada-González B; Valdés-Tapia P; León-Montes N; Ruiz-Delgado GJ
    Clin Appl Thromb Hemost; 2013; 19(6):689-92. PubMed ID: 22751911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
    Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
    Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone.
    Antoniucci D; Migliorini A; Parodi G; Valenti R; Rodriguez A; Hempel A; Memisha G; Santoro GM
    Circulation; 2004 Apr; 109(14):1704-6. PubMed ID: 15066943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between type 2 diabetes mellitus and A1/A2 polymorphism of glycoprotein IIIa gene.
    Kozieradzka A; Kamiński K; Pepiński W; Janica J; Korecki J; Szepietowska B; Musiał WJ
    Acta Diabetol; 2007 Mar; 44(1):30-3. PubMed ID: 17357883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
    Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
    J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.
    Laule M; Cascorbi I; Stangl V; Bielecke C; Wernecke KD; Mrozikiewicz PM; Felix SB; Roots I; Baumann G; Stangl K
    Lancet; 1999 Feb; 353(9154):708-12. PubMed ID: 10073513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
    Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
    J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estradiol increases platelet aggregation in Pl(A1/A1) individuals.
    Boudoulas KD; Montague CR; Goldschmidt-Clermont PJ; Cooke GE
    Am Heart J; 2006 Jul; 152(1):136-9. PubMed ID: 16824843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
    Kastrati A; Mehilli J; Nekolla S; Bollwein H; Martinoff S; Pache J; Schühlen H; Seyfarth M; Gawaz M; Neumann FJ; Dirschinger J; Schwaiger M; Schömig A;
    J Am Coll Cardiol; 2004 Mar; 43(5):734-41. PubMed ID: 14998609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.